Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation

ConclusionsThere was no clinically important pharmacokinetic interference between the Aln-NEF formulation and LT4. Aln-NEF does not materially affect LT4 absorption.

http://link.springer.com/10.1007/s00198-017-3941-3

Source: Osteoporosis International - April 13, 2017 Category: Orthopaedics Source Type: research